...
hrmy-img

Harmony Biosciences Holdings, Common Stock

HRMY

NMQ

$34.28

+$0.39

(1.15%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.93B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
16.0616
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.25M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.77
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$28.14 L
$41.61 H
$34.28

About Harmony Biosciences Holdings, Common Stock

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameHRMYSectorS&P500
1-Week Return5.84%-2.12%-3%
1-Month Return4.54%-3.42%-0.73%
3-Month Return-12.75%-11.13%2.87%
6-Month Return18.99%-5.74%7.17%
1-Year Return6.99%3.97%25.31%
3-Year Return-16.59%1.05%28.38%
5-Year Return-7.38%34.37%81.89%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue6.00M159.74M305.44M437.86M582.02M[{"date":"2019-12-31","value":1.03,"profit":true},{"date":"2020-12-31","value":27.45,"profit":true},{"date":"2021-12-31","value":52.48,"profit":true},{"date":"2022-12-31","value":75.23,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue1.58M27.74M55.52M83.48M121.24M[{"date":"2019-12-31","value":1.3,"profit":true},{"date":"2020-12-31","value":22.88,"profit":true},{"date":"2021-12-31","value":45.79,"profit":true},{"date":"2022-12-31","value":68.86,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit4.42M132.00M249.92M354.37M460.79M[{"date":"2019-12-31","value":0.96,"profit":true},{"date":"2020-12-31","value":28.65,"profit":true},{"date":"2021-12-31","value":54.24,"profit":true},{"date":"2022-12-31","value":76.91,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin73.69%82.64%81.82%80.93%79.17%[{"date":"2019-12-31","value":89.18,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":99.02,"profit":true},{"date":"2022-12-31","value":97.94,"profit":true},{"date":"2023-12-31","value":95.81,"profit":true}]
Operating Expenses150.32M115.02M162.39M234.19M268.76M[{"date":"2019-12-31","value":55.93,"profit":true},{"date":"2020-12-31","value":42.8,"profit":true},{"date":"2021-12-31","value":60.42,"profit":true},{"date":"2022-12-31","value":87.14,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(145.90M)3.68M68.70M120.19M192.03M[{"date":"2019-12-31","value":-75.98,"profit":false},{"date":"2020-12-31","value":1.92,"profit":true},{"date":"2021-12-31","value":35.78,"profit":true},{"date":"2022-12-31","value":62.59,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(12.15M)(82.15M)(74.07M)(31.17M)(30.54M)[{"date":"2019-12-31","value":-1214600000,"profit":false},{"date":"2020-12-31","value":-8215000000,"profit":false},{"date":"2021-12-31","value":-7407000000,"profit":false},{"date":"2022-12-31","value":-3116900000,"profit":false},{"date":"2023-12-31","value":-3054400000,"profit":false}]
Pre-Tax Income(151.98M)(36.94M)37.43M104.69M173.40M[{"date":"2019-12-31","value":-87.65,"profit":false},{"date":"2020-12-31","value":-21.31,"profit":false},{"date":"2021-12-31","value":21.59,"profit":true},{"date":"2022-12-31","value":60.37,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes6.07M14.91M2.83M(76.78M)44.54M[{"date":"2019-12-31","value":13.63,"profit":true},{"date":"2020-12-31","value":33.48,"profit":true},{"date":"2021-12-31","value":6.36,"profit":true},{"date":"2022-12-31","value":-172.38,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(158.05M)(51.86M)34.60M181.47M128.85M[{"date":"2019-12-31","value":-87.1,"profit":false},{"date":"2020-12-31","value":-28.58,"profit":false},{"date":"2021-12-31","value":19.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":71.01,"profit":true}]
Income From Continuous Operations(151.98M)(36.94M)34.60M181.47M150.75M[{"date":"2019-12-31","value":-83.75,"profit":false},{"date":"2020-12-31","value":-20.36,"profit":false},{"date":"2021-12-31","value":19.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":83.08,"profit":true}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(158.05M)(51.86M)34.60M181.47M128.85M[{"date":"2019-12-31","value":-87.1,"profit":false},{"date":"2020-12-31","value":-28.58,"profit":false},{"date":"2021-12-31","value":19.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":71.01,"profit":true}]
EPS (Diluted)-(2.82)0.833.132.42[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-90.1,"profit":false},{"date":"2021-12-31","value":26.52,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":77.32,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

HRMY
Cash Ratio 2.55
Current Ratio 3.24
Quick Ratio 3.20

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

HRMY
ROA (LTM) 12.85%
ROE (LTM) 22.75%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

HRMY
Debt Ratio Lower is generally better. Negative is bad. 0.36
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.64

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

HRMY
Trailing PE 16.06
Forward PE 8.58
P/S (TTM) 2.83
P/B 3.24
Price/FCF 27
EV/R 2.50
EV/Ebitda 7.83

FAQs

What is Harmony Biosciences Holdings share price today?

Harmony Biosciences Holdings (HRMY) share price today is $34.28

Can Indians buy Harmony Biosciences Holdings shares?

Yes, Indians can buy shares of Harmony Biosciences Holdings (HRMY) on Vested. To buy Harmony Biosciences Holdings from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in HRMY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Harmony Biosciences Holdings be purchased?

Yes, you can purchase fractional shares of Harmony Biosciences Holdings (HRMY) via the Vested app. You can start investing in Harmony Biosciences Holdings (HRMY) with a minimum investment of $1.

How to invest in Harmony Biosciences Holdings shares from India?

You can invest in shares of Harmony Biosciences Holdings (HRMY) via Vested in three simple steps:

  • Click on Sign Up or Invest in HRMY stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Harmony Biosciences Holdings shares
What is Harmony Biosciences Holdings 52-week high and low stock price?

The 52-week high price of Harmony Biosciences Holdings (HRMY) is $41.61. The 52-week low price of Harmony Biosciences Holdings (HRMY) is $28.14.

What is Harmony Biosciences Holdings price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Harmony Biosciences Holdings (HRMY) is 16.0616

What is Harmony Biosciences Holdings price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Harmony Biosciences Holdings (HRMY) is 3.24

What is Harmony Biosciences Holdings dividend yield?

The dividend yield of Harmony Biosciences Holdings (HRMY) is 0.00%

What is the Market Cap of Harmony Biosciences Holdings?

The market capitalization of Harmony Biosciences Holdings (HRMY) is $1.93B

What is Harmony Biosciences Holdings’s stock symbol?

The stock symbol (or ticker) of Harmony Biosciences Holdings is HRMY

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top